Your session is about to expire
← Back to Search
Speech and Language Therapy for Primary Progressive Aphasia
N/A
Waitlist Available
Led By Maya L Henry, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-treatment to post-treatment (approximately 6 weeks after treatment onset) and follow-ups at 3 months post-treatment, 6 months post-treatment, and 12 months post-treatment
Awards & highlights
Study Summary
This trial is studying whether a treatment designed to improve speech and language function can also help to slow the decline of primary progressive aphasia (PPA).
Who is the study for?
This trial is for adults with Primary Progressive Aphasia (PPA) who can pass a basic mental state exam. It's not suitable for those with major vision or hearing issues, other cognitive-linguistic affecting conditions, or significant non-speech-language impairments.Check my eligibility
What is being tested?
The study tests two speech and language therapies: Video-Implemented Script Training (VISTA) and Lexical Retrieval Training (LRT), aiming to improve communication in PPA patients. It also looks at how these treatments might change the disease's progression over a year.See study design
What are the potential side effects?
Since the interventions are behavioral therapies focusing on improving speech and language skills, there are no direct medical side effects like you'd expect from medication; however, participants may experience fatigue or frustration during therapy sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from pre-treatment to post-treatment (approximately 6 weeks after treatment onset) and follow-ups at 3 months post-treatment, 6 months post-treatment, and 12 months post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-treatment to post-treatment (approximately 6 weeks after treatment onset) and follow-ups at 3 months post-treatment, 6 months post-treatment, and 12 months post-treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in script production accuracy
Change in spoken naming of target items
Secondary outcome measures
Change on Boston Naming Test
Change on Communicative Effectiveness Index
Change on Mini Mental State Exam
+2 moreOther outcome measures
Post-treatment Communication Survey
Trial Design
2Treatment groups
Experimental Treatment
Group I: Script TrainingExperimental Treatment1 Intervention
Group II: Lexical Retrieval TreatmentExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of Texas at AustinLead Sponsor
350 Previous Clinical Trials
80,924 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
327 Previous Clinical Trials
178,155 Total Patients Enrolled
University of California, San FranciscoOTHER
2,500 Previous Clinical Trials
15,236,411 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You scored 15 or higher on a test that checks how well your brain is working.You have been diagnosed with Primary Progressive Aphasia (PPA) according to specific guidelines.You have noticeable problems with thinking, behavior, or movement, but not with speaking.I have a mental or brain condition that affects my thinking or language skills.You scored less than 15 on a test that checks memory and thinking skills.
Research Study Groups:
This trial has the following groups:- Group 1: Lexical Retrieval Treatment
- Group 2: Script Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What positive outcomes does this trial hope to bring about?
"The primary outcome of this medical trial, which will be measured at 8-12 weeks post-treatment and then again at 3, 6, and 12 months post-treatment, is change in script production accuracy. Additionally, the study will evaluate changes in communicative effectiveness, cognitive ability, and word retrieval skills."
Answered by AI
Could you provide the aggregate patient number for this research project?
"Yes, as indicated by information available on clinicaltrials.gov, this trial is still looking for participants. The trial was first posted on 7/1/2017, and the most recent update was on 3/23/2022. Currently, the study is enrolling 60 patients from 2 different hospitals."
Answered by AI
At this time, are new participants being sought for this research?
"That is accurate. The details available on clinicaltrials.gov show that this clinical trial is presently enrolling patients. The study was originally posted on 7/1/2017 and was most recently edited on 3/23/2022. They are looking for a total of 60 patients that will be split between 2 locations."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger